CD133 expression and the prognosis of colorectal cancer: a systematic review and meta-analysis - Wikidata - thesis-toulmin - TriplyDB

CD133 expression and the prognosis of colorectal cancer: a systematic review and meta-analysis

CD133 expression and the prognosis of colorectal cancer: a systematic review and meta-analysis

http://www.wikidata.org/entity/Q26827628

about

Prognostic Value of Cancer Stem Cell Marker ALDH1 Expression in Colorectal Cancer: A Systematic Review and Meta-Analysis Prognostic value of CD44 expression in renal cell carcinoma: a systematic review and meta-analysis Stem cells, colorectal cancer and cancer stem cell markers correlations Prognostic value of cancer stem cell marker CD133 in ovarian cancer: a meta-analysis From Normal Skin to Squamous Cell Carcinoma: A Quest for Novel Biomarkers Immunohistochemical detection of cancer stem cell related markers CD44 and CD133 in metastatic colorectal cancer patients.The effects of the location of cancer stem cell marker CD133 on the prognosis of hepatocellular carcinoma patients Colorectal cancers mimic structural organization of normal colonic crypts.Preoperative low dose NSAID treatment influences the genes for stemness, growth, invasion and metastasis in colorectal cancer.Comparison of putative circulating cancer stem cell detection between the hepatic portal system and peripheral blood in colorectal cancer patients Prom1 function in development, intestinal inflammation, and intestinal tumorigenesis CTC enumeration and characterization: moving toward personalized medicine.Expression of stemness genes in primary breast cancer tissues: the role of SOX2 as a prognostic marker for detection of early recurrence Effects of metformin on CD133+ colorectal cancer cells in diabetic patients Characterization and propagation of tumor initiating cells derived from colorectal liver metastases: trials, tribulations and a cautionary note Evaluation of cancer stem cell markers CD133, CD44, CD24: association with AKT isoforms and radiation resistance in colon cancer cells.Is CD133 expression a prognostic biomarker of non-small-cell lung cancer? A systematic review and meta-analysis.Concise Review: Targeting Cancer Stem Cells Using Immunologic Approaches CD133 initiates tumors, induces epithelial-mesenchymal transition and increases metastasis in pancreatic cancer Accumulation of ALDH1-positive cells after neoadjuvant chemotherapy predicts treatment resistance and prognosticates poor outcome in ovarian cancer.5-fluorouracil resistant colon cancer cells are addicted to OXPHOS to survive and enhance stem-like traits.Role of CD44(high)/CD133(high) HCT-116 cells in the tumorigenesis of colon cancer.CD133 expression may be useful as a prognostic indicator in colorectal cancer, a tool for optimizing therapy and supportive evidence for the cancer stem cell hypothesis: a meta-analysis Sciellin mediates mesenchymal-to-epithelial transition in colorectal cancer hepatic metastasis.CD133 in brain tumor: the prognostic factor.Effect of MUC1/β-catenin interaction on the tumorigenic capacity of pancreatic CD133(+) cells.Minnelide effectively eliminates CD133(+) side population in pancreatic cancer.CD133-positive tumor cell content is a predictor of early recurrence in colorectal cancer Characterization of sphere-forming HCT116 clones by whole RNA sequencing.The prognostic value of CD133 expression in non-small cell lung cancer: a meta-analysis.Prognostic significance of CD133 and ezrin expression in colorectal carcinoma.Leucine-rich repeat-containing G protein-coupled receptor 5 and CD133 expression is associated with tumor progression and resistance to preoperative chemoradiotherapy in low rectal cancer.Metformin as an anti-cancer agent: actions and mechanisms targeting cancer stem cells.CD133 expression predicts post-operative recurrence in patients with colon cancer with peritoneal metastasis.Cancer stem cells as functional biomarkers.Differential Gene Expression in Ductal Carcinoma In Situ of the Breast Based on ERBB2 Status.LGR5 and CD133 as prognostic and predictive markers for fluoropyrimidine-based adjuvant chemotherapy in colorectal cancer.CD133 Expression at the Metastatic Site Predicts Patients' Outcome in Colorectal Cancer with Synchronous Liver Metastasis.ATP-binding cassette member B5 (ABCB5) promotes tumor cell invasiveness in human colorectal cancer.Molecular profiling in colorectal cancer: current state of play and future directions

P2860

Q26774811-F415CE48-2937-4A90-9236-92B99F19814F Q26796554-8092A917-D511-4875-82C3-178C50535506 Q26823217-C498EB7D-7189-4008-A760-C1480CEB858B Q27027801-CCB2A3EE-0A62-4B85-9D88-2C81B9F1F664 Q28078702-922A8F46-5E5C-45B4-87CE-6453A861C2D0 Q33594376-751E677C-D086-4C2A-A957-3569071D1D95 Q33885293-4226D1BA-D032-426F-AA8D-D06027DFF83D Q34027850-684A9693-DAA2-496E-8ACF-92579F048FF7 Q34432882-F1741C91-669E-4FEA-8A55-AF4C7E1A065A Q34441291-546A964A-BFF0-4704-84DF-6C120BB8FE26 Q34510512-2D335CEB-EE40-4E88-A761-A4563C278953 Q34577724-BD70AD87-E2B5-4B22-A33D-CD13E1D679B5 Q34654576-D42704CA-6D8E-4A25-8B9A-14247D979A02 Q35053962-EFAAF739-C182-45F9-A6B4-8F4A9498332E Q35058046-CC244224-0512-4371-9618-2FD041D096C5 Q35156211-BAE8FB06-709C-45ED-8685-E3359B902C4A Q35190239-FB15256C-9C0A-47FF-9BED-72C9C428084A Q35772708-2B612673-CEC1-4F11-A3B2-C454F1BDF073 Q35781581-F912A796-0E48-4A2E-AB5E-FE0E97BDF626 Q36140826-A78276BF-2D0A-4163-853F-59ECAF481B01 Q36561571-642F1967-9FB3-46F1-8C31-EABDE8564718 Q36946578-AACA36B0-E5A9-4851-AFB9-CD6F9F734CC4 Q36962860-572AAE52-AE4C-4282-989C-6F8D67172463 Q37295482-74298ADA-5DD7-42D0-883E-4757B997665B Q38722833-BFB40669-8DAE-4F3D-B647-66AD953BF70B Q38747818-2394DE30-8854-4EC6-A7FA-B4C62EB3E1D2 Q38817435-6239AF20-A6C6-4E44-A1D5-5A01163443C9 Q38936641-8BFC5A4C-AE27-4E4D-B67C-045317CAAFD1 Q40015136-88AA6E8A-0F3B-4D9E-8109-8EAE24DE1F47 Q45801884-7F5EA128-C960-432E-B9BC-4F136F77EBE1 Q46403034-4448011E-D3B5-4A96-804C-D51A9D16B839 Q47119379-53BB73E2-B3C0-47AA-A3F7-53A2F470A6CC Q50001260-34E5AF00-4686-45FB-BCBB-26A1A1777522 Q50068192-0987CDFB-652A-4D4C-9799-BEC741882C52 Q50505302-A418513D-3B88-41C3-9AF4-4551A93ABD99 Q51145791-6B6CBB16-03B1-42C6-8D4D-E5847A499F79 Q51630354-44E0918A-AECC-4960-8B9C-BE840257B536 Q52886460-A3B2B6AC-F10B-48BE-A32C-699F342F1DDB Q54107810-476F0D57-DB28-4A8B-9E6B-F0D0C493C199 Q54687516-6E8E7A06-DBC0-4FF2-B2A5-D8E22574CEA4

P2860

CD133 expression and the prognosis of colorectal cancer: a systematic review and meta-analysis

http://www.wikidata.org/entity/Q26827628

description

2013 nî lūn-bûn

@nan

2013 թուականի Փետրուարին հրատարակուած գիտական յօդուած

@hyw

2013 թվականի փետրվարին հրատարակված գիտական հոդված

@hy

2013年の論文

@ja

2013年論文

@yue

2013年論文

@zh-hant

2013年論文

@zh-hk

2013年論文

@zh-mo

2013年論文

@zh-tw

2013年论文

@wuu

name

CD133 expression and the progn ...... matic review and meta-analysis

@ast

CD133 expression and the progn ...... matic review and meta-analysis

@en

CD133 expression and the progn ...... matic review and meta-analysis

@nl

type

label

CD133 expression and the progn ...... matic review and meta-analysis

@ast

CD133 expression and the progn ...... matic review and meta-analysis

@en

CD133 expression and the progn ...... matic review and meta-analysis

@nl

prefLabel

CD133 expression and the progn ...... matic review and meta-analysis

@ast

CD133 expression and the progn ...... matic review and meta-analysis

@en

CD133 expression and the progn ...... matic review and meta-analysis

@nl

P1433

Q26827628-12CFAC3D-AD59-460B-8AA0-0DE46B506B3F

P1476

Q26827628-91F4C9AC-BF39-48D2-826D-DACE17821CAD

P2093

Q26827628-100DD724-E1AC-498F-BC99-A10C4DA6467D

Q26827628-285EF41E-8B55-4C0E-B756-0B4481F93982

Q26827628-77483D9E-8AC6-4439-9399-9A97F87E55B2

Q26827628-8E9F40C7-E711-4688-8C86-FC98DBFFE1B1

Q26827628-9DBCA938-D512-46B0-842C-9CD9EB1E3319

Q26827628-ACCECACE-6142-4595-A9F1-C93E73FF3801

Q26827628-FB59B347-04F8-4AF8-996E-738CC2334622

P275

Q26827628-58EF31F9-969F-4590-B9B1-E49E4FBA62DE

P2860

Q26827628-132D3659-75C4-4583-A95A-EC4F87529C05

Q26827628-14F6B1B0-6884-4064-8273-DA803D921D82

Q26827628-191E4E93-52E1-40F8-8821-785F0B922303

Q26827628-19A70E2B-C909-4CDC-AC9F-99646EE01DCF

Q26827628-1BF4120A-087D-438D-85C2-10A0B3E66D08

Q26827628-1F8E890D-3FC0-4C27-ACA6-4BFF6944B3CF

Q26827628-222B5D1E-7C02-42DE-BB7B-41A1CCCB87EF

Q26827628-22EED0EF-3E5D-42BD-9D02-BE6625873F1C

Q26827628-24E02B51-6C7D-4E43-BADF-92FAFB45EC8F

Q26827628-261DE1BC-785F-457E-8E62-79F62A251E6D

P304

Q26827628-465A1D5E-9BDA-425E-9654-3AAA96AC8613

P31

Q26827628-40896C07-1049-402B-9944-0F8B81C96CA5

Q26827628-44792497-B4C7-4984-B99C-04FC6F50A9B6

Q26827628-859E951A-43DB-454E-B45F-0A88D85B137D

Q26827628-9D1F2C73-A1C1-44AF-A38F-A6F3ADAFB2AF

P3181

Q26827628-11151E28-D55C-4808-95B4-8014DA2CC547

P356

Q26827628-A3B2DAB9-F960-4734-B1DB-7F527006A909

P407

Q26827628-ED2BBCA8-2ECE-4964-90F7-97700FF7ECD5

P433

Q26827628-AA0BE7B0-CC97-4785-B543-B73DC27D9DF0

P478

Q26827628-9BD0098D-3F2E-4490-8C22-08B68F7E78D6

P5008

Q26827628-9D7DD747-A5CA-4A52-9FD9-818431ECBB2B

P577

Q26827628-3F8B5C0F-97BB-4CEA-B329-534B4430FCA5

Q26827628-F3DD50BA-D3C0-429A-802C-93CE1BEB50CA

P5875

Q26827628-076A320B-3276-42AD-95BE-BEC658770B14

P698

Q26827628-68B33F16-C480-47A5-87DA-C320E03CDC86

P921

Q26827628-1B633996-1AE4-4758-99EE-B416CC4A4E13

Q26827628-26D7010D-1824-41B7-B859-2CCB4FAD0054

Q26827628-9D2B5F32-08D4-4BD8-862F-8DDDE3CAF1E6

Q26827628-DE352A32-90D7-4B40-AE6A-7BC5BDA27AFE

Q26827628-F63B061A-A978-4302-91DF-A012E7E9E290

Q26827628-F9B68224-5496-4035-A06E-672B17286159

P932

Q26827628-1B769CBB-BAD5-4421-A4E9-BF377ACDD219

P3181

P356

JOURNAL.PONE.0056380

P1433

P1476

CD133 expression and the progn ...... matic review and meta-analysis

@en

P2093

Haiying Liu

http://www.w3.org/2001/XMLSchema#string

Jianchang Li

http://www.w3.org/2001/XMLSchema#string

Mingzhe Li

http://www.w3.org/2001/XMLSchema#string

Shicai Chen

http://www.w3.org/2001/XMLSchema#string

Xinming Song

http://www.w3.org/2001/XMLSchema#string

Xinxin Li

http://www.w3.org/2001/XMLSchema#string

Zhihui Chen

http://www.w3.org/2001/XMLSchema#string

P275

Creative Commons Attribution 4.0 International

P2860

Higher percentage of CD133+ cells is associated with poor prognosis in colon carcinoma patients with stage IIIB

CD133 expression is not restricted to stem cells, and both CD133+ and CD133- metastatic colon cancer cells initiate tumors

Identification and expansion of human colon-cancer-initiating cells

Operating characteristics of a rank correlation test for publication bias

A human colon cancer cell capable of initiating tumour growth in immunodeficient mice

Identification of human brain tumour initiating cells

Meta-analysis of Observational Studies in Epidemiology: A Proposal for Reporting

AC133, a novel marker for human hematopoietic stem and progenitor cells

Prognostic significance of the cancer stem cell markers CD133, CD44, and CD166 in colorectal cancer

Cancer stem cell marker CD133+ tumour cells and clinical outcome in rectal cancer

P304

e56380

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

systematic review

P3181

3925688

http://www.w3.org/2001/XMLSchema#string

P356

10.1371/JOURNAL.PONE.0056380

http://www.w3.org/2001/XMLSchema#string

P407

P433

2

http://www.w3.org/2001/XMLSchema#string

P478

8

http://www.w3.org/2001/XMLSchema#string

P5008

P577

2013-01-01T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

2013-02-11T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P5875

235622193

http://www.w3.org/2001/XMLSchema#string

P698

23409180

http://www.w3.org/2001/XMLSchema#string

P921

Angliavandeniai

colorectal cancer

regulation of gene expression

colorectal neoplasm

P932

3569427

http://www.w3.org/2001/XMLSchema#string